Luca Benatti, Director at INTERCEPT PHARMACEUTICALS, INC. (ICPT), bought 1,200 shares at $83.50 ($100K) on 2019-05-14, disclosed to the SEC on 2019-05-14.
Open-market purchase of $100k ICPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |